Retroviral Transmission and Breast‐feeding

Clinical Microbiology and Infection

Volumn 1, Issue 1, 1995, Pages 6-12

  van de Perre, Philippe ^a   Cartoux, Michel ^a  

^a CENTRE MURAZ   (Burkina Faso)

Author keywords

breast milk; colostrum; HIV 1; HTLV I; lentiviruses; Oncogenic viruses; postnatal transmission; recommendations.; risk factors

Indexed keywords

EID: 85005087588     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1995.tb00017.x     Document Type: Review

References (81)

1. Some possible effects of nursing on mammary gland tumor incidence in mice
2. Pathogenesis of retroviral‐induced disease
3. The transmission of the virus of myeloid leukemia of mice by the milk
4. Retroviral spongiform polioencephalo‐myopathy
5. Bovine leukosis: natural transmission and principles of control
6. Virus‐like particles in cow's milk from a herd with a high incidence of lympho‐sarcoma
7. Bovine lymphosarcoma transmission studies
8. Zum Einfluß der Leukosebekämpfung auf die Entwicklung der enzootischen Rinderleukose in Niedersaschsen
9. Erythroleukemia in two infant chimpanzees fed milk from cows naturally infected with bovine C‐type virus
10. Lentiviral disease of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis
11. Experimental visna in Icelandic sheep: the prototype lentiviral infection
12. A Trojan horse mechanisms for the spread of visna virus in monocytes
13. Studies in epidemiology of maedi/visna in sheep
14. Transmission and control of caprine arthritis‐encephalitis virus infection
15. Global survey of serological evidence of caprine arthritis—encephalitis virus infection
16. Isolation of a T‐lymphotropic virus from domestic cats with an immunodeficiency‐like syndrome
17. Vertical transmission of feline immunodeficiency virus
18. Feline immunodeficiency virus can be experimentally transmitted via milk during acute maternal infection
19. RNA‐dependent DNA polymerase activity in virus‐like particles isolated from human milk
20. Search for a human breast cancer virus
21. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T‐cell lymphoma
22. Isolation and characterization of retrovirus from cell lines of human adult T‐cell leukemia and its implications in disease
23. Mother‐to‐child transmission of human T‐cell leukemia virus type I (HTLV‐I): a fifteen‐year follow‐up study in Okinawa, Japan
24. Milk‐borne transmission of HTLV‐I as a major route in the endemic cycle
25. Transmission of adult T‐cell leukemia retrovirus (HTLV‐I) from mother to child: comparison of bottle‐ with breast‐fed babies
26. Bottle‐feeding can prevent transmission of HTLV‐I from mothers to their babies
27. Vertical transmission of human T‐cell lèukemia type I
28. Demonstration of adult T‐cell leukemia virus antigen in milk from three seropositive mothers
29. DNA amplification of human T lymphotropic virus type I (HTLV‐I) proviral DNA in breast milk of HTLV‐I carriers
30. Oral transmission of human T‐cell leukemia virus type I into a common marmoset (Calithrix jacchus) as an experimental model for milk‐borne transmission
31. Oral transmission of human T‐cell leukemia virus type I in the rabbit
32. Mother‐to‐offspring transmission of human T‐cell leukemia virus type I in rabbits
33. Milk‐borne transmission of human T‐cell leukemia virus type I in rabbits
34. tax protein of human T‐cell lymphotropic virus type I on mother‐to‐child transmission
35. Prevention of mother‐to‐child transmission of human T‐lymphotropic virus type I
36. Trans‐acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells
37. tax protein of human T‐cell leukemia virus I and infectivity
38. Immunoglobulm prophylaxis against milk‐borne transmission of human T‐cell leukemia virus type I in rabbits
39. Rates of mother‐to‐child transmission of HIV in Africa, America and Europe: results from 13 perinatal studies
40. Reasons for the wide variation in reported rates of mother‐to‐child transmission of HIV‐1
41. Epidemiology and determinants of vertical HIV transmission
42. Maternal factors involved in mother‐to‐child transmission of HIV‐1. Report of a consensus workshop, Siena, Italy: January 17–18, 1992
43. Maternal vitamin A deficiency and mother‐to‐child transmission of HIV‐1
44. Prospective comparison of mother‐to‐child transmission of HIV‐1 and HIV‐2 in Abidjan, Côte d'Ivoire
45. Virological and electron microscopic evidence for postnatal HIV transmission via breast milk (abstract no. 5099)
46. Infective and anti‐infective properties of breast milk from HIV‐1‐infected women
47. Prevalence of HIV‐1 DNA and p24 antigen in breast milk and correlation with maternal factors
48. Isolation of AIDS virus from cell‐free breast milk of three healthy virus carriers
49. Postnatal transmission of human immunodeficiency virus type ***1 from mother to infant. A prospective cohort study in Kigali, Rwanda
50. Breast‐feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant
51. Postnatal transmission of the human immunodeficiency virus type 1 and the breast‐feeding dilemma
52. Risk of human immunodeficiency virus type 1 transmission through breast‐feeding
53. High titer of cytopathic virus in plasma of patients with symptomatic primary HIV‐1 infection
54. Postnatal transmission of HIV‐1 associated with breast abscess
55. An assessment of the timing of mother‐to‐child transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction
56. Mother‐to‐infant transmission of HIV by breast milk: presumed innocent or presumed guilty
57. Transient seroconversion in children born to HIV‐1‐infected mothers
58. HIV‐1 seroconversion after 20 months of age in a cohort of breastfed children born to HIV‐1‐infected women in Rwanda
59. Mother‐to‐child transmission of human immunodeficiency virus type 1: report from the Nairobi study
60. Resumption of breast‐feeding in later childhood: a risk factor for mother‐to‐child human immunodeficiency virus type 1 transmission
61. Zidovudine to decrease mother‐to‐child transmission of HIV‐1; is it good for developing countries
62. A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor
63. Human immunodeficiency virus antibodies of the IgG, IgA and IgM subclasses in the milk of seropositive mothers
64. Antibodies to human immunodeficiency virus in the breast milk of healthy, seropositive women
65. Human immunodeficiency virus type 1 IgA antibody in breast milk and serum
66. HIV‐1 transmission through breast‐milk: appraisal of risk according to duration of feeding
67. Quantifying the risk of HIV‐1 transmission via breast milk
68. Cytomegalovirus infection of breast milk and transmission in infancy
69. Does breast‐feeding delay progression to AIDS in HIV‐infected children
70. Epidemiology of human T‐cell leukemia/lymphoma virus
71. Inactivation of lymphocyte‐transforming activity of human T‐cell leukemia virus type 1 by heat
72. Prevention of HTLV‐I transmission through the breast milk by freeze‐thawing process
73. Infant feeding policy and practice in the presence of HIV‐1 infection
74. Global Programme on AIDS. Consensus statement from the WHO/UNICEF consultation on HIV transmission and breast‐feeding
75. Reduction of maternal‐infant transmission of human immunodeficiency virus type 1 with ZDV treatment
76. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus
77. Interventions to reduce mother‐to‐child transmission of HIV‐1
78. Colostrum and ideas about bad milk: a case study from Guinea‐Bissau
79. HIV infection, breastfeeding, and the human milk banking